Neurizon Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Apr '26 Apr 28, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2016
Market Capitalization	63	79	87	26	22	29	Upgrade
Market Cap Growth	22.03%	-9.23%	232.99%	17.48%	-23.03%	-38.43%	Upgrade
Enterprise Value	57	69	81	25	21	27	Upgrade
Last Close Price	0.09	0.16	0.19	0.07	0.07	0.09	Upgrade
PS Ratio	10.55	51.22	103.10	29.83	4.92	7.88	Upgrade
PB Ratio	7.61	27.93	8.48	6.70	2.83	3.25	Upgrade
P/TBV Ratio	7.61	27.93	8.48	33.34	4.68	5.02	Upgrade
EV/Sales Ratio	9.49	44.64	96.62	28.74	4.61	7.28	Upgrade
Debt / Equity Ratio	0.20	-	-	0.27	0.18	0.14	Upgrade
Net Debt / Equity Ratio	-0.76	-1.48	-1.05	-0.43	-0.13	-0.20	Upgrade
Net Debt / EBITDA Ratio	0.43	0.25	1.85	1.27	0.71	1.58	Upgrade
Net Debt / FCF Ratio	0.36	0.29	2.08	1.05	0.75	1.68	Upgrade
Asset Turnover	0.39	0.20	0.10	0.11	0.43	0.34	Upgrade
Inventory Turnover	-	-	-	-	0.31	0.24	Upgrade
Quick Ratio	1.98	2.73	12.00	2.13	2.24	3.58	Upgrade
Current Ratio	2.18	2.84	12.42	2.24	3.20	4.78	Upgrade
Return on Equity (ROE)	-147.09%	-254.33%	-126.09%	-26.80%	-20.43%	-15.37%	Upgrade
Return on Assets (ROA)	-60.21%	-136.74%	-42.14%	-12.71%	-9.63%	-7.33%	Upgrade
Return on Capital Employed (ROCE)	-179.20%	-599.50%	-56.90%	-34.50%	-18.20%	-12.70%	Upgrade
Earnings Yield	-23.54%	-21.07%	-8.84%	-23.84%	-7.70%	-4.64%	Upgrade
FCF Yield	-27.68%	-18.15%	-5.96%	-6.13%	-6.20%	-3.61%	Upgrade
Buyback Yield / Dilution	-14.98%	-31.44%	-15.51%	-1.30%	-0.36%	-6.66%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.